treatment for HIV
Improving Maternal Mortality and Other Aspects of Women's Health,
Published by:
Center For Strategic and International Studies(CSIS)
Over the past several decades, the world has witnessed some astonishing global health success stories—from the eradication of smallpox to the expanding control of other vaccine-preventable diseases to the widespread provision of effective treatment for HIV/AIDS to millions of people. Yet, for all these public health and medical advances, a startling number of women still die each year from causes linked to pregnancy and childbirth: 287,000, according to the most recent consensus estimates. Eighty-five percent of these deaths occur in sub-Saharan Africa and South Asia. Many if not most are thought to be avoidable given adequate maternal access to emergency obstetric care.
Public HAART Projects in South Africa - Progress to November 2004
Published by:
Health Systems Trust
Between late 1999 and the year 2000, various operational research projects, primarily investigating the integration of highly active antiretroviral therapy (HAART) with public sector services, were started at different levels of care within the public health sector. Following the initial work on operational research the expansion of HAART provision was delayed by the absence of a national treatment plan.
Public Sector HAART Projects - A Summary Report
Published by:
Health Systems Trust
The National Department of Healths Operational Plan for Comprehensive HIV and AIDS Care Management and Treatment for South Africa, launched in November 2003, emphasises the provision of comprehensive care and treatment for people living with HIV/AIDS and the need to strengthen the national health system in South Africa.
Cost-Effectiveness of Antiretroviral Treatment for HIV-Positive Adults in a South African Township
Published by:
Health Systems Trust
Introduction: This study aims to establish the costs and effectiveness of antiretroviral therapy (ART) for HIV positive adults in a resource-constrained public-sector setting. The research compares ART to the current status quo for HIV-positive adults who are dependent on the public sector for care in South Africa i.e the treatment of opportunistic and HIV- elated infections and events (e.g. wasting) in the absence of ART. This research is clearly important in the developing country context, where the HIV epidemic is expected to have a dramatic impact on life expectancy and to lead to early mortality for a large proportion of the population (Dorrington, Bourne et al. 2001). This study presents the first cost-effectiveness results derived from a public sector clinic-based treatment programme. Cost, effectiveness and quality of life data have been collected from a single cohort receiving care in three HIV-dedicated clinics in Khayelitsha, a township on the outskirts of Cape Town. This setting is similar to what will be encountered in the public sector ART rollout.



